86. Biotech-Hoffnung mRNA, mit Herrn Dr. Hömke (VfA)

from Der Anleger Podcast · host Effecten Spiegel

„Forschen ist die beste Medizin“, so titelte es der ES bereits und nahm die mRNA-Forschung einmal genauer unter die Lupe. Im Podcast-Interview bespricht der ES die Forschungsfortschritte und Einsatzgebiete der künftigen mRNA-Therapien mit Herrn Dr. Hömke, Forschungssprecher vom Verband forschender Arzneimittelhersteller (VfA). Schreibt uns: [email protected] www.effecten-spiegel.com

Episode metadata supplied by the publisher feed · Published Oct 2, 2021

Embed this episode

Attribution link and audio player

Ready to play

86. Biotech-Hoffnung mRNA, mit Herrn Dr. Hömke (VfA)

0:00 20:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Der Anleger Podcast?

This episode is 20 minutes long.

When was this Der Anleger Podcast episode published?

This episode was published on October 2, 2021.

Can I download this Der Anleger Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!